VALUE OF INNOVATION IN ONCOLOGY TREATMENTS FOR PATIENTS IN SWEDEN WITH ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER

被引：0
|
作者：
Justo, N. [1 ]
Nilsson, J. [1 ]
Korytowsky, B. [2 ]
Chehab, N. [2 ]
Stanford, A. [3 ]
Mcguire, A. [4 ]
机构：
[1] MAPI Grp, Stockholm, Sweden
[2] Bristol Myers Squibb, Plainsboro, NJ USA
[3] Pfizer Inc, Mcpherson, KS USA
[4] London Sch Econ, London, England
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.1522
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN189
引用
收藏
页码：A167 / A167
页数：1
相关论文
共 50 条
  • [21] Comorbidity in clinical trial patients with advanced or metastatic non-small cell lung cancer (NSCLC).
    Kosov, Maxim
    Kumar, Akhil
    Belotserkovskiy, Maxim
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [22] Role of Rebiopsy in Relapsed Non-Small Cell Lung Cancer for Directing Oncology Treatments
    Jekunen, Antti P.
    [J]. JOURNAL OF ONCOLOGY, 2015, 2015
  • [23] Prognostic value of neuron-specific enolase in patients with advanced and metastatic non-neuroendocrine non-small cell lung cancer
    Yan, Peng
    Han, Yiming
    Tong, Anna
    Liu, Jie
    Wang, Xinyu
    Liu, Chuanyong
    [J]. BIOSCIENCE REPORTS, 2021, 41 (08)
  • [24] Treatment of locally advanced and metastatic non-small cell lung cancer in the elderly
    Zimmermann, FB
    Molls, M
    Jeremic, B
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2004, 18 (01) : 203 - +
  • [25] Effectiveness and cost of gefitinib in advanced/metastatic non-small cell lung cancer
    Selvi-Sabater, P.
    Sanchez-Martinez, I.
    Sadyrbaeva-Dolgova, S.
    Portillo-Haro, S.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (01) : 289 - 289
  • [26] EFFECTIVENESS AND SAFETY OF PEMBROLIZUMAB IN ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
    Murteira, R.
    Ramos, C.
    Cardoso Borges, F.
    Ferreira, M. M.
    Miranda, A.
    da Costa, Alves F.
    [J]. VALUE IN HEALTH, 2018, 21 : S15 - S15
  • [27] The safety and efficacy of nivolumab in advanced (metastatic) non-small cell lung cancer
    Tanvetyanon, Tawee
    Creelan, Benjamin C.
    Antonia, Scott J.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (09) : 903 - 910
  • [28] Prognostic value of neutrophil to lymphocyte ratio in patients with advanced non-small cell lung cancer
    Koukidou, Sofia
    Charpidou, Andriani
    Vassos, Dimitrios
    Grapsa, Dimitra
    Ampelioti, Sevasti
    Dimakou, Ekaterini
    Bakakos, Petros
    Poulakou, Garyphallia
    Syrigos, Konstantinos
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [29] The Value of Hope: Patients' and Physicians' Preferences for Survival in Advanced Non-Small Cell Lung Cancer
    Hauber, Brett
    Penrod, John R.
    Gebben, David
    Musallam, Lina
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2020, 14 : 2093 - 2104
  • [30] Prognostic Value of the Lung Immune Prognostic Index for Patients Treated for Metastatic Non-Small Cell Lung Cancer
    Kazandjian, Dickran
    Gong, Yutao
    Keegan, Patricia
    Pazdur, Richard
    Blumenthal, Gideon M.
    [J]. JAMA ONCOLOGY, 2019, 5 (10) : 1481 - 1485
12345